China NMPA Product Recall - Palindrome Precision H Chronic Catheter for Hemodialysis

The National Medical Products Administration (NMPA) has publicized a voluntary Class III recall initiated by medical device manufacturer Covidien LLC, reported through its subsidiary, Covidien Medical Devices International Trading (Shanghai) Co., Ltd. The announcement, made on April 3, 2024, concerns specific batches of the Palindrome Precision H Chronic Catheter, identified by National Medical Device Registration Certificate No. 20233100345. The core issue prompting this recall is the discovery that certain central venous catheters intended for hemodialysis treatment are missing their crucial heparin coating. This coating is typically vital for preventing blood clot formation and ensuring the safe and effective long-term use of such devices. Under the NMPA's regulatory oversight, companies are mandated to ensure the safety and quality of medical products. The manufacturer, Covidien LLC, has proactively undertaken this recall to address the product non-conformity and mitigate potential risks to patients. A Class III recall indicates a situation where there is a low probability that the use of, or exposure to, a violative product will cause adverse health consequences. The required action involves the collection and correction of the affected batches of the Palindrome Precision H Chronic Catheter from the market to safeguard patient health. Comprehensive details regarding the specific models, specifications, and affected product batches are provided within the official Medical Device Recall Event Report Form.